JPWO2022079161A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022079161A5 JPWO2022079161A5 JP2023523019A JP2023523019A JPWO2022079161A5 JP WO2022079161 A5 JPWO2022079161 A5 JP WO2022079161A5 JP 2023523019 A JP2023523019 A JP 2023523019A JP 2023523019 A JP2023523019 A JP 2023523019A JP WO2022079161 A5 JPWO2022079161 A5 JP WO2022079161A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- component
- therapeutic molecule
- kda
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063092251P | 2020-10-15 | 2020-10-15 | |
| US63/092,251 | 2020-10-15 | ||
| US202163250782P | 2021-09-30 | 2021-09-30 | |
| US63/250,782 | 2021-09-30 | ||
| PCT/EP2021/078433 WO2022079161A1 (en) | 2020-10-15 | 2021-10-14 | Non-covalent protein-hyaluronan conjugates for long-acting ocular delivery |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023546112A JP2023546112A (ja) | 2023-11-01 |
| JPWO2022079161A5 true JPWO2022079161A5 (https=) | 2024-10-23 |
| JP2023546112A5 JP2023546112A5 (https=) | 2024-10-23 |
Family
ID=78483243
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023523019A Pending JP2023546112A (ja) | 2020-10-15 | 2021-10-14 | 長時間作用型眼送達用非共有結合タンパク質－ヒアルロナンコンジュゲート |
| JP2023523034A Pending JP2023545514A (ja) | 2020-10-15 | 2021-10-14 | 治療薬の長時間作用型送達のためのバーシカン（ｖｇ１）のヒアルロン酸結合誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023523034A Pending JP2023545514A (ja) | 2020-10-15 | 2021-10-14 | 治療薬の長時間作用型送達のためのバーシカン（ｖｇ１）のヒアルロン酸結合誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20230279090A1 (https=) |
| EP (2) | EP4228706A1 (https=) |
| JP (2) | JP2023546112A (https=) |
| KR (2) | KR20230088743A (https=) |
| CN (1) | CN116390767A (https=) |
| AU (2) | AU2021360935A1 (https=) |
| CA (2) | CA3198668A1 (https=) |
| IL (2) | IL302087A (https=) |
| TW (2) | TW202228790A (https=) |
| WO (2) | WO2022079161A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118718181A (zh) | 2019-06-05 | 2024-10-01 | 里珍纳龙药品有限公司 | 用于精确剂量递送的装置及方法 |
| USD1120314S1 (en) | 2022-11-30 | 2026-03-24 | Regeneron Pharmaceuticals, Inc. | Dose delivery device |
| WO2025242919A1 (en) * | 2024-05-24 | 2025-11-27 | Navigo Proteins Gmbh | Novel binding proteins for hyaluronic acid |
| WO2026022392A1 (en) * | 2024-07-26 | 2026-01-29 | Ospedale San Raffaele S.R.L. | Peptide and conjugates thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5144088A (en) | 1991-04-26 | 1992-09-01 | Aristech Chemical Corporation | Manufacture of neopentyl glycol (I) |
| JP3957765B2 (ja) | 1997-04-07 | 2007-08-15 | ジェネンテク・インコーポレイテッド | 抗ｖｅｇｆ抗体 |
| DE60140474D1 (de) | 2000-09-08 | 2009-12-24 | Univ Zuerich | Sammlung von proteinen mit sich wiederholenden sequenzen (repeat proteins), die repetitive sequenzmodule enthalten |
| US7771742B2 (en) | 2004-04-30 | 2010-08-10 | Allergan, Inc. | Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods |
| LT3216803T (lt) | 2008-06-25 | 2020-06-10 | Novartis Ag | Stabilūs ir tirpūs antikūnai, slopinantys vegf |
| US20140248296A1 (en) * | 2008-10-16 | 2014-09-04 | Kathleen Cogan Farinas | Sustained drug delivery system |
| US8133979B2 (en) | 2008-12-16 | 2012-03-13 | Hoffmann-La Roche Inc. | Antibodies against human angiopoietin 2 |
| LT3495387T (lt) | 2012-07-13 | 2021-11-25 | Roche Glycart Ag | Bispecifiniai anti-vegf / anti-ang-2 antikūnai ir jų panaudojimas akių kraujagyslių ligoms gydyti |
| EP2935589A1 (en) | 2012-12-18 | 2015-10-28 | Novartis AG | Compositions and methods that utilize a peptide tag that binds to hyaluronan |
| US10434188B1 (en) * | 2013-06-04 | 2019-10-08 | The Trustees Of Indiana University | Hyaluronic acid binding domain-growth factor fusion protein cDNAs and fusion proteins for cartilage matrix preservation and repair |
| CN105008791B (zh) | 2013-08-06 | 2017-08-29 | 奥林巴斯株式会社 | 光源光学系统、光纤光源、显微镜和汽车用前照灯 |
| WO2015198243A2 (en) | 2014-06-25 | 2015-12-30 | Novartis Ag | Compositions and methods for long acting proteins |
| WO2016073157A1 (en) | 2014-11-06 | 2016-05-12 | Genentech, Inc. | Anti-ang2 antibodies and methods of use thereof |
| PT3215530T (pt) | 2014-11-07 | 2019-11-21 | Sesen Bio Inc | Anticorpos de il-6 melhorados |
| CA3012718A1 (en) * | 2016-02-08 | 2017-08-17 | Vitrisa Therapeutics, Inc. | Compositions with improved intravitreal half-life and uses thereof |
-
2021
- 2021-10-14 CA CA3198668A patent/CA3198668A1/en active Pending
- 2021-10-14 EP EP21816202.2A patent/EP4228706A1/en active Pending
- 2021-10-14 JP JP2023523019A patent/JP2023546112A/ja active Pending
- 2021-10-14 WO PCT/EP2021/078433 patent/WO2022079161A1/en not_active Ceased
- 2021-10-14 KR KR1020237015502A patent/KR20230088743A/ko active Pending
- 2021-10-14 TW TW110138224A patent/TW202228790A/zh unknown
- 2021-10-14 TW TW110138197A patent/TW202228789A/zh unknown
- 2021-10-14 AU AU2021360935A patent/AU2021360935A1/en active Pending
- 2021-10-14 IL IL302087A patent/IL302087A/en unknown
- 2021-10-14 AU AU2021361108A patent/AU2021361108A1/en active Pending
- 2021-10-14 IL IL302089A patent/IL302089A/en unknown
- 2021-10-14 KR KR1020237015789A patent/KR20230088749A/ko active Pending
- 2021-10-14 CA CA3198810A patent/CA3198810A1/en active Pending
- 2021-10-14 JP JP2023523034A patent/JP2023545514A/ja active Pending
- 2021-10-14 WO PCT/US2021/054965 patent/WO2022081835A1/en not_active Ceased
- 2021-10-14 CN CN202180070823.XA patent/CN116390767A/zh active Pending
- 2021-10-14 EP EP21801429.8A patent/EP4228702A1/en active Pending
-
2023
- 2023-04-14 US US18/301,187 patent/US20230279090A1/en active Pending
- 2023-04-14 US US18/301,180 patent/US20230256107A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6023703B2 (ja) | 改善された安定性を有するフィブロネクチンをベースとする足場タンパク質 | |
| TWI698447B (zh) | 用於抑制血管新生之融合蛋白 | |
| EP3268386B1 (en) | Fusion protein comprising a ligand binding domain of vegf and pdgf. | |
| JP5270753B2 (ja) | 抗血管形成化合物 | |
| EP4034551A1 (en) | Cytokine prodrugs and dual-prodrugs | |
| JP2023058590A (ja) | 骨標的抗体 | |
| CN102816242A (zh) | 在体内具有延长的半衰期和增强的红细胞生成活性的重组人EPO-Fc融合蛋白 | |
| JP2012529891A5 (https=) | ||
| CN117467025B (zh) | 一种抗vegf和补体双功能融合蛋白及其应用 | |
| JP2014501515A (ja) | 改良された抗血清アルブミン結合単一可変ドメイン | |
| JP2016027801A (ja) | 改良された抗血清アルブミン結合変異体 | |
| JPWO2022079161A5 (https=) | ||
| TW202227471A (zh) | 白介素15構建體和使用方法 | |
| JPWO2022081835A5 (https=) | ||
| JP7813054B2 (ja) | コイルドコイル融合タンパク質 | |
| US9388397B2 (en) | Deimmunized gelonin molecules and therapies | |
| KR20230046999A (ko) | 코일드 코일 융합 단백질 | |
| KR20240113641A (ko) | 종양 표적 전달체, mmp 절단서열, 항암펩티드 및 세포투과펩티드를 포함하는 종양 표적화 항체 융합단백질 플랫폼 | |
| WO2018219301A1 (zh) | 一种PDGFRβ靶向性肿瘤坏死因子相关凋亡诱导配体变异体及其制备方法和用途 | |
| US20220363778A1 (en) | Targeted delivery of tumor matrix modifying enzymes | |
| CN116162148A (zh) | 多特异性配体结合分子及其应用 | |
| JP2025528881A (ja) | 単鎖可変断片の改変タンパク質 | |
| KR20240026436A (ko) | 단일쇄 가변 단편의 변이 단백질 | |
| JPWO2021222295A5 (https=) | ||
| EA051126B1 (ru) | Конструкции интерлейкина-15 и способы применения |